Trial Profile
An Experimental Medicine Study to Characterise the Importance of IL-18 Production and to Evaluate the Therapeutic Potential of IL-18 Blockade With GSK1070806 in Subjects With Behcet's Disease
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs GSK 1070806 (Primary)
- Indications Behcet's syndrome
- Focus Adverse reactions
- 15 May 2018 New trial record